Mavens Biotech Ltd has submitted to BSE a copy of the statement of deviation or variation in public issue, right issue, preferential issue etc. for the quarter ended December 31, 2016.
Ask Value Research 
News Announcement
Mavens Biotech: Statement of deviation or variation for the quarter ended December 31, 2016
12-Jan-2017
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
